 |
| Stacey Bernstein |
Stacey Bernstein, executive VP & global director of digital health at Weber Shandwick, has joined M Booth Health as CEO.
She succeeds Tim Bird, who is taking on the chairman role as he transitions to a consulting role at the Next 15 Communications Group unit.
Bernstein, who also served as general manager of Weber’s Boston outpost, did a nearly dozen-year run at the Interpublic PR flagship.
She joined Weber from Edelman, where she did a four-year stint.
Bernstein will report to M Booth CEO Dale Bornstein.
She praised Bird for “the leadership and vision that brought his agency under the M Booth umbrella.”
Next 15 acquired Health Unlimited’s US division, which was headed by Bird, in 2019.
Health Unlimited and its specialist consultancy Corkery Group were rebranded as M Booth Health, which took the No. 12 slot in O’Dwyer’s rankings of healthcare PR firms with $14.4M in fees for 2020.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
